Human metapneumovirus-associated community-acquired pneumonia in adults during the first wave of COVID-19

Kenya SUMITOMO; Shun MORIZUMI; Kiyohide TAKAHASHI; Masaaki KIMURA; Hirofumi KODA; Yuko TOYODA; Tsutomu SHINOHARA

Return

Human metapneumovirus-associated community-acquired pneumonia in adults during the first wave of COVID-19

VernacularTitle:Human metapneumovirus-associated community-acquired pneumonia in adults during the first wave of COVID-19
Author: Kenya SUMITOMO ¹ ; Shun MORIZUMI ¹ ; Kiyohide TAKAHASHI ² ; Masaaki KIMURA ¹ ; Hirofumi KODA ³ ; Yuko TOYODA ⁴ ; Tsutomu SHINOHARA ⁵
Author Information

1. Division of Internal Medicine, Japan Agricultural Cooperatives Kochi Hospital, Japan
2. Department of Community Medicine for Respirology, Graduate School of Biomedical Sciences, Tokushima University, Japan
3. Department of Pharmacy, Japan Agricultural Cooperatives Kochi Hospital, Japan
4. Division of Clinical Laboratory, Japan Agricultural Cooperatives Kochi Hospital, Japan
5. Department of Respiratory Medicine, Japanese Red Cross Kochi Hospital, Japan
Keywords: human metapneumovirus; community-acquired pneumonia; COVID-19; SARS-CoV-2; differential diagnosis
From:Journal of Rural Medicine 2021;16(4):263-269
CountryJapan
Language:English
Abstract: Objective: The clinical course of human metapneumovirus (hMPV) infection is similar to that of coronavirus 2019 disease (COVID-19). However, community-acquired hMPV infections in adults have not yet been sufficiently investigated. We examined the detection status of hMPV antigens and the clinical features of positive patients during the first wave of COVID-19, which coincided with the epidemic season of hMPV infection in Japan.Methods: In this cross-sectional, observational, and single-center study, we recruited consecutive individuals who visited the Japan Agricultural Cooperatives Kochi Hospital due to fever, respiratory symptoms, or close contact with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infected persons during the period from January to May 2020.Results: The positive rate of immunochromatography for hMPV antigens from nasopharyngeal swabs was 9.5% (4/42), and four positive cases were community-acquired pneumonia (CAP) (5.3% of all CAP). The positive rate of hMPV antigens in the CAP group (30.8%, 4/13) was higher than that in the non-pneumonia group (0.0%, 0/19) (p < 0.05). The average age of the four adult patients with CAP was 69.8 years (range 35–93). Mean white blood cell counts and C-reactive protein blood levels were 6,250 cells/μL (3,500–12,180) and 4.30 mg/dL (4.05–7.04), respectively. Chest computed tomography images were diverse and two patients showed dense consolidation. No multi-organ disorder was noted during the clinical course in any of the four cases, and their prognoses were good.Conclusion: hMPV infection may be considered in the differential diagnosis of COVID-19 and CAP in Japan under the preventive measures for SARS-CoV-2 infection, at least during the epidemic season of hMPV infection.